The Global Resource For Connecting Buyers and Sellers

WntResearch Delays Start of Phase 2 Study With Foxy-5

STOCKHOLM, Feb. 13, 2018 /PRNewswire/ — WntResearch AB announces today that, after reviewing available research results and further consultations with experts in oncology and surgery, the company has revised the design of the planned Phase 2 clinical study of its drug candidate Foxy-5….